In the News | Friends of Cancer Research

You are here

In the News

October 25, 2018
Friends of Cancer Research (Friends) recognized Senators Orrin Hatch (R–UT) and Michael Bennet (D–CO) for responding to a recently identified public health issue and proposing a solution to an issue... Read more
October 25, 2018
The Friends of Cancer Research (Friends) recently announced the launch of phase II of its tumor mutational burden Harmonization Project, as the research team finalizes data collected from phase I in... Read more
October 17, 2018
On July 9, 2012, officials signed the Food and Drug Administration Safety and Innovation Act (FDASIA) which had a section within it that established a new designation—the Breakthrough Therapy... Read more
September 28, 2018
Senators Hatch and Bennet Introduce Bipartisan Solution to Important Public Health Issue September 28, 2018 – Washington, DC – Friends of Cancer Research (Friends) applauds Senators Orrin Hatch (R-UT... Read more
September 28, 2018
A bipartisan duo of senators wants to give the Food and Drug Administration the power to add off-label uses to certain generic drug labels.   Sens. Orrin Hatch (R-Utah) and Michael Bennet (D-Colo.)... Read more
September 26, 2018
Real-life studies have become increasingly important in the scientific world in recent years. Although they have numerous limitations, they have the advantage of better representing the population... Read more
September 26, 2018
The Oregon Health Authority is weighing a recommendation to deny Medicaid coverage for next-generation sequencing tests in the state.   If enacted, Oregonians who rely on Medicaid for cancer... Read more
September 25, 2018
On August 8, ASCO and Friends of Cancer Research (Friends) submitted recommended language to the U.S. Food and Drug Administration (FDA) for five guidance documents on ways to broaden eligibility... Read more
September 18, 2018
September 18, 2018 – Washington, DC – Today, Friends of Cancer Research (Friends) announced the launch of Phase II of its tumor mutational burden or TMB Harmonization Project as the TMB harmonization... Read more
September 17, 2018
Commissioner Scott Gottlieb is scaling up FDA efforts to assert control over laboratory developed tests, saying in a speech that the agency would take a flexible approach — but first needs the power... Read more